The U.S. Food and Drug Administration (FDA) has cleared a noninvasive add-on feature for a test that detects heart patterns in people with pulmonary hypertension (PH). The new tool in the Corvista-PH test estimates the likelihood of elevated pulmonary capillary wedge pressure (PCWP), a key marker of heart failure. The…
Discussion
When I was recently discharged from the hospital following a stint with COVID-19 and norovirus, my team automatically scheduled me for an in-person follow-up. As the date in July approached, I double-checked the appointments in my online portal and noted a few things. First, I had been scheduled for…
Discussion
There’s a sentiment that a book finds you at the right time in your life. Sometimes, when you have a chronic illness like pulmonary hypertension (PH), that book finds you when you’re sitting on a bench outside of a hospital. Recently, that book for me was “Famesick,”…
Discussion
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to IKT-001, an experimental formulation of imatinib that Inhibikase Therapeutics is developing to treat pulmonary arterial hypertension (PAH). The FDA gives orphan drug designation to investigational medications that aim to treat rare diseases, defined as conditions…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
